NCT06923098Recruiting
PET/CT GUIDED BIOPSY VERSUS CT GUIDED BIOPSY IN EVALUATION OF SUSPECTED LUNG NEOPLASMS
Source: ClinicalTrials.gov · Last updated 11 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Percutaneous CT guided biopsy is a well-established, standard sampling technique for suspected neoplastic lesions located in peripheral region in lung parenchyma. Inconclusive results on CT guided biopsy is substantially higher in large lung lesions which are prone to cause peripheral pneumonia, atelectasis and even regional necrosis, which are hard to be distinguished from tumor on CT images. Functional imaging guided biopsy like PET/CT guided biopsy identifies areas of highest concentration of neoplastic cells and provides accurate results. Only a few studies have been done regarding PET/CT guided biopsy and studies omparing PET/CT guided and CT guided percutaneous transthoracic lung biopsy are very few and this study would be a randomized trial comparing these diagnostic modalities in terms of diagnostic yield, diagnostic accuracy of sample and complications.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 108 (estimated)
- First submitted
- 4 Apr 2025
- Start date
- 1 Jul 2023
- Primary completion date
- Jul 2025
- Lead sponsor
- All India Institute of Medical Sciences, Bhubaneswar
- Diseases
- Lung cancer
- NCT number
- NCT06923098
What you commit to
- Study type: Interventional
- Planned participants: 108
- From 1 Jul 2023 to the primary completion date, Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- Participants with pre-existing bleeding diathesis like hemophilia, coagulopathy defined by -INR ≥1.2 and Platelet counts ≤ 80,000/mm3
- Serum creatinine level more than 2mg/dl.
Other
- Participants who refuse to provide consent
- Signs of hypoperfusion like hypotension, cyanosis etc.
- Presence of hypoxemia with SpO2 \< 94 %- measured in a pulse oximeter)
- Pregnant/Lactating female subjects
- Non-cooperative subjects
- Lesions that are inaccessible (decision made on pre-biopsy planning)
Who the study is looking for
- Age above 18 years
- INR \< 1.2 and platelet counts \> 80,000/mm3
- CT thorax with lung lesion more than 10 mm.
- Accessible lesions for CT-guided biopsy.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| All India Institute of Medical Sciences, Bhubaneswar Coordinator of this site? Confirm its status | Bhubaneswar | India | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.